January 15, 2020  PARIS–(BUSINESS WIRE)–Regulatory News: EOS imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI – Eligible PEA – PME), a leader in 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and surgical planning, today announces its unaudited full-year sales for the financial year ending December 31, 2019. €21.4 million total revenues generatedover the year 2019, …